Form D · Biotechnology
Qualigen Therapeutics, Inc.
Carlsbad, CA · CIK 0001460702
Offering snapshot reported Aug 13, 2025 · SEC filing
- Reported sold
- $4.5M Offering amount: $4.5M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jul 28, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2025 | Initial | $4,500,000 | No comparison | 14 | SEC filing |
| Nov 22, 2024 | Initial | $5,100,000 | No comparison | 33 | SEC filing |
| Nov 9, 2018 | Initial | $6,000,000 | No comparison | 11 | SEC filing |
| Dec 16, 2014 | Initial | $3,693,875 | No comparison | 4 | SEC filing |
| Nov 22, 2013 | Amendment | $7,366,914 | $1,565,369vs Aug 7, 2012 | 16 | SEC filing |
| Aug 7, 2012 | Amendment | $5,801,545 | $3,851,018vs Nov 30, 2010 | 14 | SEC filing |
| Feb 23, 2012 | Initial | $526,445 | No comparison | 1 | SEC filing |
| Nov 30, 2010 | Initial | $1,950,527 | No comparison | 8 | SEC filing |
| Oct 12, 2010 | Initial | $250,000 | No comparison | 2 | SEC filing |
| Mar 19, 2010 | Initial | $452,569 | No comparison | 1 | SEC filing |
| Aug 17, 2009 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Mar 17, 2009 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-554645
No sales commission or finder's fees
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Univest Securities LLC | 000036105 |
Source: Form D, filed Aug 13, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Adamek | Director |
| Campbell Becher | Director, Executive |
| John W. Beck | Executive |
| Graydon Bensler | Director |
| Noah Doyle | Director |
| Matthew W. Foehr | Director |
| Williams Lee | Promoter |
| Braeden Lichti | Director |
| Robert B. Lim | Director |
| Paul V. Maier | Director |
| Steven Markowitz | Director |
| William M. Merino | Director |
| Cody Price | Director |
| Kevin Richardson Ii | Director |
| Andrew J. Ritter | Director, Executive |
| Ira E. Ritter | Director, Executive |
| Mike Step | Director |
| Michael D. Step | Director |
| Lee Williams | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5857 Owens Avenue Suite 300
Carlsbad, CA, 92008
Carlsbad, CA, 92008